N-(3-(4H-1,2,4-Triazol-4-yl)phenyl)acetamide, 95%, 1g

ethyl (2Z)-2-chloro-2-[2-(3-chloro-2-methylphenyl)hydrazin-1-ylidene]acetate, 95.0%, 10g

Sample tub Type 2117, 250 ml, 4 Piece(s)

(R)-Piperidin-2-ylmethanol, 95.0%, 250mg

ETHYL 4-HYDROXYPYRROLO[2,1-F][1,2,4]TRIAZINE-5-CARBOXYLATE, 95.0%, 100mg

5-(Trifluoromethoxy)-2,3-dihydro-1H-inden-1-one, 98%, 250mg

8-Ethynyl-1,4-dioxaspiro[4.5]decane, 98%, 1g

2-Isopropyl-N,2,3-trimethylbutanamide, 95.0%, 100g

5-Chloro-2-fluoropyridine, 97.0%, 25g

Ethyl 6-bromo-5-hydroxy-1-methyl-2-((phenylthio)methyl)-1H-Indole-3-carboxylate, 98%, 500g

Diphenyl carbonate, 95.0%, 1kg

1-(2-Amino-6,7-dihydro-4H-thiazolo[5,4-c]pyridin-5-yl)-ethanone, 95.0%, 25g

tert-Butyl benzyl(5-chloro-3-isopropylpyrazolo[1,5-a]pyrimidin-7-yl)carbamate, 97%, 10g